by Shi-qi An | Jan 8, 2026 | News
Abselion’s CEO and Founder, Ruizhi Wang, has been featured in a multi-contributor article published by Technology Networks, sharing industry perspectives on how laboratory environments are evolving. The article brings together voices from across the life sciences to...
by Shi-qi An | Dec 15, 2025 | News
BioCompare’s 2026 outlook brings together perspectives from across the life sciences, including insights from Abselion’s Founder & CEO, Dr. Ruizhi Wang, on the evolving needs of biologics discovery and development. BioCompare has published “A Look Ahead:...
by Shi-qi An | Nov 28, 2025 | News
News-Medical publishes interview with Abselion on His-tagged protein analysisl News-Medical has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, discussing how researchers are using the Amperia™ platform to support reliable His-tagged protein...
by Shi-qi An | Oct 30, 2025 | News
Technology Networks features Abselion in discussion on advancing AAV quantification Technology Networks has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, exploring the challenges of AAV capsid quantification and the need for more...
by Shi-qi An | Oct 7, 2025 | News
Biocompare highlights Abselion among industry voices shaping mAb characterization In Biocompare’s editorial The Evolving Landscape of mAb Characterization, leaders from across the biologics field — including Abselion CEO Dr Ruizhi Wang — discuss how emerging...
by Shi-qi An | Oct 6, 2025 | News
Abselion article published in International Biopharmaceutical Industry (IBI) Autumn 2025 We are pleased to announce that Abselion’s article has been published in the Autumn 2025 issue of International Biopharmaceutical Industry (IBI). Co-authored by Professor Alan...
